9th Annual Biomarkers Congress

Oncology: Harvard University

Total Score People Score Events Score
212 157 59
Date Event Presentation Speakers
April 28, 2014 Companion Diagnostics: From Biomarker Identification to Market Entry Genomics Medicine Raju Kucherlapati
September 4, 2013 Partnerships in Clinical Trials Asia 2013 Turning Potential into Reality within Asia Pacific: Examining the Relationship between Commercial Viability and Clinical Research Activity Jonathan Wang
July 23, 2013 EpiCongress Boston Epigenetic Regulation Of Resistance To Anti-Cancer Drugs Jeffrey Settleman
May 31, 2013 ASCO Annual Meeting 2013 Optimizing the Role of Advanced Practice Professionals in Oncology Practice Lawrence N. Shulman
Hot Pathways for Targeted Therapy of B-Cell Malignancies James E. Bradner
Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer Ian E. Krop
Clinical Management, Molecular Alterations, and Future Perspectives in Urothelial Cancer David Kwiatkowski
Cancer Stem Cells: A New and Better Target in Pediatric Oncology? Scott A. Armstrong, George Daley
Reaping the Rewards of the Cancer Genome Atlas Project Levi A Garraway
Improving Cancer Care through Health Information Technology: Ethics and Practicality Lawrence N. Shulman
Education Sessions Robert G Maki, Stephen T Sonis
Education Sessions Deborah Schrag
Education Sessions Tracy T Batchelor
Education Sessions Michael B. Atkins, Jennifer A. Ligibel
Educations Sessions Monica M. Bertagnolli
Education Sessions Bruce E. Johnson, Elizabeth R. Gerstner
May 28, 2013 NGS Translate In Vivo Dynamics of the Microbiota: Development of Computational Models for Time Series Analyses Lynn Bry
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
January 31, 2013 5th Immunotherapeutics & Immunomonitoring KEYNOTE PRESENTATION Jeffrey J. Popma
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Regenerative Medicine David T Scadden
Career-Development Lunch Sessions D. Gary Gilliland, Daniel J. DeAngelo, David Avigan, Ellis J. Neufeld
October 31, 2012 The 4th Annual Life Sciences Summit "Academic Drug Discovery: Emerging Models Designed to Advance Academic Discoveries" Marcie Glicksman
September 13, 2012 International Society of Gastrointestinal Oncology Transarterial Embolic Therapy for Liver-Predominant NETs: Bland vs. Chemoembolization vs. Radioembolization David R Liu
March 4, 2012 "Cellular Oncology" new insights leading to clinical advancement" "Cellular Oncology" new insights leading to clinical advancement" Dai Fukumura
December 4, 2011 Update in Internal Medicine Oncology: Challenging Cases with Your Participation Lowell E Schnipper
Oncology Q & A Lowell E Schnipper
Cancer: From Bench to Bedside Lowell E Schnipper
Introduction and Welcome Martin J Abrahamson
New Frontiers in Radiology Jonathan B. Kruskal
Endocrinology Q & A Martin J Abrahamson
Endocrinology: Challenging Cases with Your Participation Martin J Abrahamson
Treatment of Type 2 Diabetes 2011: Advances, Challenges and Opportunities Martin J Abrahamson
The Evaluation and Management of Common Disorders of the Knee C. Christopher Smith
Panel Discussion Martin J Abrahamson
Delivering Customer Service Excellence Martin J Abrahamson
Hypertension 2011: Recent Trials and Rational Therapy Gerald W. Smetana
November 18, 2011 16th Annual Perspectives In Thoracic Oncology Role of EGFR TKIs as frontline therapy in mutation positive patients with NCSLC Lecia Sequist
EML4/ALK and other new biomarkers and their therapeutic implications Lecia Sequist
October 16, 2011 the 15th annual Update and Review of Internal Medicine 2011 welcome and Introduction Martin J Abrahamson
Endocrinology Q & A Martin J Abrahamson
A practical Approach to the diagnosis and Management of Thyroid disease Martin J Abrahamson
New drugs for the pcp 2011 | what You Need to Know Gerald W. Smetana
panel discussion Gerald W. Smetana
Treatment of Type 2 diabetes 2011 | Update Martin J Abrahamson
Hypertension | New Strategies for Your practice Gerald W. Smetana
Oncology | challenging cases with Your participation Lowell E Schnipper
Oncology Q & A Lowell E Schnipper
cancer | From the Bench to the Bedside Lowell E Schnipper
October 2, 2011 31st Annual Oncology Nurses Symposium Early Palliative Care Constance Dahlin
July 6, 2011 3rd WIN Symposium SESSION 3 | NEW BIOMARKER STRATEGIES IN CLINICAL TRIALS D. Gary Gilliland
ROUND TABLE - PANEL OF EXPERTS - FORUM OF OPEN DISCUSSION WITH ATTENDEES | Monotherapies or combined therapeutics? Clinically addressing the complexity of molecular pathways in cancer: How can we develop the most relevant combination beyond individual Pharma/Biotech pipelines: a risk sharing approach for the benefit of the patient D. Gary Gilliland
Predicting efficacy of therapeutics in clinical trials | filling the gap between pre-clinical models and phase I clinical trials D. Gary Gilliland
New targets and innovative therapeutics Kenneth C Anderson
May 18, 2011 SBI 10th Postgraduate Course Challenging Cases MRI (Audience Response System) Sughra Raza
Gerald Dodd Lecture | Biology Of Breast Cancer Stuart J Schnitt
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Adaptive Immunity against Cancer? | Mechanisms of Protective Tumor Immunity Glenn Dranoff
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities From genomics to personalized medicine in oncology Levi A Garraway
Title to be announced Deborah Schrag
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved From genomics to personalized medicine in oncology Levi A Garraway
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Opening Remarks Rakesh K Jain
Tumor Microenvironment I: Angiogenesis and Vascular Transport Rakesh K Jain
Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapy: from Bench to Bedside to Biomarkers Rakesh K Jain
Tumor Microenvironment II: Interstitial and Lymphatic Transport Rakesh K Jain
Tumor Stroma Generation: Role of VPF/VEGF Harold F. Dvorak
Mining the Human Proteome: Biomarker Discovery for Human Cancer and Its Metastases Marsha Moses
Genetics in Cancer Therapy Raju Kucherlapati
Imaging Angiogenesis and Vascular Function in Cancer Patients A. Gregory Sorensen
July 15, 2010 Breast Cancer: Current Controversies | New Horizons Challenging Cases – Early Stage Disease Eric P. Winer, Jane E. Brock, Craig A. Bunnell, Michelle Gadd, Steve Isakoff, Rinaa Punglia, Elizabeth Rafferty
Do All Patients with DCIS Need Radiation After Conservative Surgery? Julia Wong
Modern Surgical Approaches to DCIS Mehra Golshan
The Pathology of DCIS and Other Pre-Invasive Lesions Laura C. Collins
SESSION II – PRE-INVASIVE DISEASE Kevin S. Hughes
Modifiable Breast Risk Factors: Alcohol, Diet, and Exercise Wendy Y. Chen
SESSION I – RISK AND SCREENING Judy E Garber
Welcoming Remarks Eric P. Winer
Pathology Assessment After Preoperative Therapy Andrea Richardson
Imaging the Patient Receiving Preoperative Therapy Eren Yeh
Preoperative Therapy for Triple Negative Disease Judy E Garber
Lunch Served | Challenging Multidisciplinary Cases – Early Stage and Advanced Disease Jay R Harris, MD, Harold J. Burstein, Paula D Ryan, Melinda J. Lerwill, Jerry Younger
Tumor Heterogeneity: The Real Challenge Kornelia Polyak
Angiogenesis Inhibitors: A Major Advance? Erica L Mayer
HER2+ Breast Cancer: The Present and Future Ian E. Krop
SESSION IV – ADVANCED BREAST CANCER Eric P. Winer
K. CYP2D6 Testing Harold J. Burstein, Kathryn Ruddy
I. Managing Menopausal Symptoms Jennifer A. Ligibel
H. Adjuvant Treatment in the Elderly Rachel Freedman, Michael J. Hassett
G. New Targets for Triple Negative Breast Cancer Daniel P. Silver
F. Special Considerations for Managing Breast Cancer in Young Women Lidia Schapira, Ann H Partridge
C. Role of Surgery in Stage IV Disease SUSAN TROYAN, Sara M. Tolaney
New England Journal Of Medicine Clinicopathological Conference | Patient with Inflammatory Breast Cancer Beth Overmoyer
Breast Reconstruction: Which Option for Which Patient? Stephanie Caterson
Post-Mastectomy Radiation for Fewer than Four Nodes Jay R Harris, MD
Surgical Management of the Patient with a Positive Sentinel Node SUSAN TROYAN
Innovation in Lumpectomy and Mastectomy Surgery Barbara Smith
SESSION V – ADVANCES AND CONTROVERSIES IN LOCAL THERAPY Michelle C. Specht
Picking the Optimal Adjuvant Endocrine Therapy for Pre-Menopausal Women Ann H Partridge
SESSION VII – ADJUVANT THERAPY Barbara Smith
ASCO Update Harold J. Burstein
Susan E. Donelan "hope For The Future" Lecture | A Balancing Act: Comparative Effectiveness vs. Efficacy and the Cancer Research Agenda Deborah Schrag
Concluding Remarks and Adjourn Eric P. Winer
Frontiers in the Adjuvant Treatment of HER2+ Disease Eric P. Winer
May 19, 2010 Towards Personalized Cancer Medicine New Cancer Targets Emerging From Studies of the von Hippel-Lindau Tumor Suppressor Protein William G Kaelin
Functionalizing the Cancer Genome Lynda Chin
SESSION III: Oncogenomics and Tumor Profiling Lynda Chin
Target and Drug Discovery in Oncology: The Right Drug for the Right Patient D. Gary Gilliland
PANEL DISCUSSION Lynda Chin
April 30, 2010 Drug Story KEYNOTE PRESENTATION Joshua LaBaer
April 30, 2010 UCSF Radiation Oncology Update: Management of Recurrent Disease Buschke Lecture: The Relationship Between Local Recurrence and Survival in Breast Cancer Jay R Harris, MD
Approaches for Endometrial Recurrence Phillip M. Devlin
January 29, 2010 9th Annual UCSF Clinical Cancer Update Update in Bladder Cancer Jonathan Rosenberg
November 14, 2009 Clinical Medical Ethics Ethical Reflections on Dr. Testa’s Proposal Dan Brock
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Keynote Lecture: Pursuing Placebo: From Noise to Signal Ted Kaptchuk
November 6, 2009 Translating Scientific Advances Into Clinical Care for Cancer Lung Cancer Thomas J. Lynch
November 2, 2009 Track 1: Seventh Annual RNAi for Screening Cellular Pathways and Targets Title to be Announced Stephen J Elledge
Efficient Vectors for in vivo RNAi and Construction of a Drosophila Genome-wide Transgenic RNAi Collection Norbert Perrimon
Chairperson’s Opening Remarks Norbert Perrimon
October 16, 2009 Eighth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy Update on Hereditary Breast Cancer Syndromes: Prophylaxis and Treatment Paula D Ryan
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Case Presentation 1: Stage II David Ryan
September 24, 2009 Track 3:Advancing Cancer Therapy : Inaugural Circulating Tumor Cells Genome-Subtractive Cancer-Specific Blood Assay Amin L Kassis
September 23, 2009 Track 3: Advancing Cancer Therapy : Second Annual Translational Cancer Medicine The Use of Genetically Engineered Mice for Preclinical Testing of Novel Cancer Therapeutics Kwok-Kin Wong
August 10, 2009 Second Annual Trends in Cancer Diagnostics EGFR and Beyond: Evolution of a Molecular Classification and Treatment Strategy for Lung Cancer Neal Lindeman
August 5, 2009 New Frontiers in Cancer Drug Development A New Paradigm for Translational Cancer Research: Targeting Endocrine Factors and Real Human Tumors Sandra S. McAllister
Turning Cancer Sequencing Data into Therapeutic Targets Heidi Greulich
Combinations of Novel and Conventional Cancer Agents: Challenges and Opportunities Kenneth C Anderson
The Use of Genetically Engineered Mouse Lung Cancer Models to Assess Effectiveness of Targeted Therapeutic Combinations Kwok-Kin Wong
The Evolving Treatment Paradigm in Multiple Myeloma Kenneth C Anderson
July 22, 2009 Eighth International Congress on the Future of Breast Cancer Targeting Metastases Andrea L Richardson, Shyamala Maheswaran
Triple-Negative Breast Cancer Andrea L Richardson
February 3, 2009 Cancer Health Disparities PLENARY SESSION 1: GENETIC DETERMINANTS OF CANCER RISK ACROSS POPULATIONS Matthew L Freedman
CONCURRENT SESSIONS Martin G Sanda
January 26, 2009 7th Annual Partnering with Central Labs Track A : Central Lab Cost Drivers and Logistics Discussion Forum David Mooney
January 21, 2009 Advances in Prostate Cancer Research SESSION 2: PTEN Pier Paolo, Levi A Garraway
SESSION 5: TUMOR MICROENVIRONMENT Randolph S Watnick
January 5, 2009 High Content Analysis Multi-Color Live Cell Immunofluorescence Timecourse Analysis of Human-Induced Pluripotent Stem Cell Formation Thorsten M Schlaeger
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) TBD Yu-Li Wang
Co-Chair :Track 2-8 Zhen Y. Jiang
Analyzing Insulin Signaling Networks and Metabolic Functions Using Quantitative Proteomics Approach :Track 2-8 Zhen Y. Jiang
Oral Delivery of Glucan Encapsulated siRNA to Macrophages Targeting Map4K4 Attenuates Systemic Inflammation :Track 2-8 Myriam Aouadi
Developmental Origin of Adipose Tissue: Novel Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism :Track 2-8 Yu-Hua Tseng
Title: TBD : Track 4-4 Jing X. Kang
November 23, 2008 Advanced Technology in Radiation Oncology Activity Of Bevacizumab Against NF2-Related Vestibular Schwannomas. Scott Plotkin
November 21, 2008 The 13th Annual Scientific Meeting of the Society for Neuro-Oncology Response and Outcome Assessment in NeuroOncology: Update Patrick Y. Wen
Phase I/II Study Of Erlotinib And Temsirolimus (CCI-779) For Patients With Recurrent Malignant Gliomas (NABTC 04-02). Patrick Y. Wen
November 20, 2008 The 13th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology Introduction and Overview Patrick Y. Wen
Resistance to Cytotoxic Therapies Arnab Chakravarti
Inducing Apoptosis and Inhibiting Autophagy Andrew Kung
Biology of RNAi William C Hahn
Delivery of RNAi to brain tumors Khalid Shah
October 31, 2008 Changing Paradigms in Lung Cancer Care and Advances in the Pipeline Therapeutic Workshop Thomas J Lynch
October 30, 2008 44th ASCO Annual Meeting General Session I: Minimal Residual Disease and Circulating Tumor Cells Lecia Sequist
General Session II: Identifying Patients for EGFR Inhibitor Therapy: Markers of Response and Resistance Bruce E. Johnson
General Session II: Identifying Patients for EGFR Inhibitor Therapy: Markers of Response and Resistance (continued Pasi A Janne
General Session IV: Molecular Markers of Response and Resistance to Angiogenesis Inhibitors Tracy T Batchelor, Rakesh K Jain
Organizing Commitee Bruce E. Johnson
Scientific Commitee Bruce E. Johnson
October 21, 2008 20th EORTC - NCI - AACR Symposium on "Molecular Targets and Cancer Therapeutics" Plenary session 3 Proteasome Kenneth C Anderson
June 27, 2008 American Society of Clinical Oncology New Presentation Philip Kantoff
General Session IV: Gastrointestinal (Non-Colorectal) Cancer Peter C Enzinger
General Session VI: Breast Cancer – Metastatic Erica L Mayer
General Session VIII: Myeloma Kenneth C Anderson
Program Commitee Arthur T Skarin, Bruce E. Johnson
General Session XII: Patient and Survivor Care Janet L Abrahm
General Session IX: Leukemia David Avigan
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Proof of Concept to Pre-Clinical Scientist George Daniel Demetri
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer genetics-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer prevention/epidemiology-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
clinical trials-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
ethics-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
gastrointestinal (noncolorectal) cancer-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy George Daniel Demetri
geriatric oncology--Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
lung cancer-- Targeted and Novel Agents in Small Cell Lung Cancer Bruce E. Johnson
melanoma/skin cancers-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
patient and survivor care-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
patient and survivor care-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
pediatric cancer-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
pediatric cancer-- Challenges and Optimizing Outcomes in Adolescents and Young Adults with Cancer Karen H. Albritton
pediatric cancer-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
pediatric cancer-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
sarcoma/bone and soft tissue cancers-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
sarcoma/bone and soft tissue cancers-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
tumor biology-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
meet the professor sessions-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
April 28, 2008 Clinical Development of Therapeutic Antibodies Normalizing Tumor Vessels and Microenvironment to Treat Cancer: From the Bench to Bedside and Back Rakesh K Jain
March 25, 2008 PATHWAY ANALYSIS Chairperson’s Remarks Tara M Love
Not miR-ly Small RNAs: Genetic Approach to Defining microRNA Pathways Tara M Love
March 25, 2008 CANCER MOLECULAR MARKERS Therapeutic Potential of Targeting microRNAs in Chronic Myeloid Leukemia Tara M Love
Chairperson’s Remarks Tara M Love
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Title to be announced William G Kaelin
Clinical Targeting and Inhibition of Tyrosine Kinases in GIST and Sarcomas: Lessons for Cancer Therapy and Future Directions George Daniel Demetri
RNAi, NON-CODING RNA, AND microRNA William C Hahn
Functional Genomics, Experimental Models, and Cancer William C Hahn
January 18, 2008 Translational Research Program Stem Cell Symposium Circulating Endothelial Cells Dan G Duda
November 15, 2007 2007 Fourth International Conference 1. Models of Integrative Oncology Programs Panel David S. Rosenthal
1. Models of Integrative Oncology Programs Panel David S. Rosenthal
November 6, 2007 Chemotherapy Foundation Symposium XXV ASPARAGINE DEPLETION IN TREATMENT OF ADULTS WITH ALL Daniel J. DeAngelo
GIST: TARGETING PATHOGENIC PATHWAYS AND DEVELOPING NEW AGENTS George Daniel Demetri
SYSTEMIC THERAPY FOR BREAST CANCER BRAIN METASTASES Nancy U. Lin
SATRAPLATIN UPDATE A. Oliver Sartor
Dinner & Special Presentations Educational Grant: Bayer HealthCare/Onyx Pharmaceuticals Andrew Zhu
October 11, 2007 Sixth International Colorectal Cancer Congress What’s New in Virtual Colonoscopy? Joseph Ferrucci
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.